James Cregg
4PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 08, 2025
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers.James Cregg, Anne V Edwards, Stephanie Chang
|Feb 24, 2025
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers.James Cregg, Kristof Pota, Aidan C A Tomlinson
|Apr 09, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.Jingjing Jiang, Lingyan Jiang, Benjamin J Maldonato
Pageof 1
Frequent Collaborators
4 joint publications
Elena S Koltun
2 joint publications
Jingjing Jiang
2 joint publications
Abby Marquez
2 joint publications
Benjamin J Maldonato
2 joint publications
Matthew Holderfield
2 joint publications
Adrian L Gill
2 joint publications
Kyle J Seamon
2 joint publications
John E Knox
2 joint publications
Zhican Wang
2 joint publications
Xing Wei